72130-68-8

Basic information

• Product Name: ethyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-8-carboxylate
• Synonyms: ethyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-8-carboxylate;7-HYDROXY-5-OXO-1,2,3,5-TETRAHYDRO-INDOLIZINE-8-CARBOXYLIC ACID ETHYL ESTER;1,2,3,5-Tetrahydro-7-hydroxy-5-oxo-8-indolizinecarboxylic acid ethyl ester;7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine -8-carboxylate ethyl
• CAS NO: 72130-68-8
• Molecular Formula: C₁₁H₁₃NO₄
• Molecular Weight: 223.23
• Mol File: 72130-68-8.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 368.872 °C at 760 mmHg
• Flash Point: 176.888 °C
• Appearance: /
• Density: 1.36
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.593
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: ethyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-8-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-8-carboxylate(72130-68-8)
• EPA Substance Registry System: ethyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-8-carboxylate(72130-68-8)

Safety Data

• Hazardous Substances Data: 72130-68-8(Hazardous Substances Data)

Usage

General Description

Ethyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-8-carboxylate is a synthetic compound with a complex chemical structure. It is an ester, derived from the indolizine ring system and containing a hydroxy group on the 7th carbon, a carbonyl group on the 5th carbon, and an ethyl ester group on the 8th carbon. Ethyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-8-carboxylate is not naturally occurring and is primarily used in research and pharmaceutical development. Its specific properties and potential applications may vary, but it is likely to have biological or pharmacological activity due to its unique structure and functional groups. Further studies and testing are necessary to fully understand the potential uses and effects of Ethyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-8-carboxylate.

InChI:InChI=1/C11H13NO4/c1-2-16-11(15)10-7-4-3-5-12(7)9(14)6-8(10)13/h6,13H,2-5H2,1H3

Upstream product

• 35150-22-2 (Z)-ethyl 2-(pyrrolidin-2-ylidene)acetate 
• 1663-67-8 malonoyl dichloride 
• 5264-35-7 2-methoxy-1-pyrroline 
• 105-50-0 diethyl 1,3-acetonedicarboxylate 

Downstream Products

• 1193487-32-9 7-(4-bromo-2-fluoro-phenylamino)-5-oxo-1,2,3,5-tetrahydro-indolizine-8-carboxylic acid cyclopropyl-methoxy-amide 
• 1193488-35-5 7-(4-Bromo-2-fluoro-phenylamino)-6-methyl-5-oxo-1,2,3,1-tetrahydro-indolizine-8-carboxylic acid (2-vinyloxy-ethoxy)-amide 
• 1193487-42-1 7-(4-bromo-2-fluoro-phenylamino)-6-methyl-5-oxo-1,2,3,5-tetrahydro-indolizine-8-carboxylic acid ethyl ester 
• 1193487-43-2 7-(4-bromo-2-fluoro-phenylamino)-6-methyl-5-oxo-1,2,3,5-tetrahydro-indolizine-8-carboxylic acid 
• 1193487-31-8 7-(4-bromo-2-fluoro-phenylamino)-5-oxo-1,2,3,5-tetrahydro-indolizine-8-carboxylic acid 
• 1193487-30-7 7-(4-bromo-2-fluoro-phenylamino)-5-oxo-1,2,3,5-tetrahydro-indolizine-8-carboxylic acid ethyl ester 
• 1150098-45-5 7-(4-bromo-2-fluoro-phenylamino)-6-methyl-5-oxo-1,3,5,1-tetrahydro-indolizine-8-carboxylic acid (2-hydroxy-ethoxy)-amide 
• 116993-48-7 3-benzyl-4-hydroxy-8,9-dihydro-7H-pyranno<3,2-f>indolizin-2,5-dione 
• 116993-49-8 4-hydroxy-3-phenyl-8,9-dihydro-7H-pyranno<3,2-f>indolizin-2,5-dione 
• 58156-35-7 7-hydroxy-2,3-dihydro-1H-indolizin-5-one 
• 116993-42-1 7-Hydroxy-8-(ethoxycarbonyl)-6-methyl-2,3-dihydro-1H-indolizin-5-one 

Relevant articles and documents

Propionic Acid Derivatives and Methods of Use Thereof

Provided herein are compounds and pharmaceutical compositions of formula I where R1, R2, R3, R4, R5 and R6 are as described herein. Also provided pharmaceutically acceptable salts or stereoisomers of these compounds. In addition methods are provided for inhibiting the binding of an integrin to treat various pathophysiological conditions.

Heterocyclic Compounds as MEK Inhibitors

The present invention relates to compounds of formula I and pharmaceutically acceptable salts. These compounds can act as potential MEK inhibitors in the treatment of hyperproliferative diseases, like cancer and inflammation. The present invention also reveals methods of preparation thereof.

Annulation of heterocyclic secondary enamines with dicarboxylic acid dichlorides, an unexpected ring size effect

Under very mild conditions heterocyclic secondary enamines react efficiently with malonyl chloride to produce hydroxylated 2-pyridinone-fused heterocycles. The reactions of enamines with oxalyl chloride, however, afford varied products depending upon the heterocyclic structure of the enamine. Whilst a C-acylated enamine and a lactam-fused heterocycle were obtained from the reaction of the five- and seven-membered heterocyclic enamines, respectively, the six-membered heterocyclic enamine gave 2-oxo-5,6,7,8-tetrahydro-2H-pyrido[3,2-b]pyran. The reaction mechanisms are discussed.